Office-based buprenorphine treatment of opioid use disorder /:
With a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD)-an increasingly important topic as the epide...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Arlington, Virginia :
American Psychiatric Association Publishing,
[2018]
|
| Ausgabe: | Second edition. |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | With a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD)-an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States. Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice. This new edition of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women's health and pregnancy. A discussion of the Comprehensive Addiction and Recovery Act (CARA). Advice for working with Alcoholics Anonymous and Narcotics Anonymous. A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs. -- Publisher. |
| Beschreibung: | Preceded by Handbook of office-based buprenorphine treatment of opioid dependence, edited by John A. Renner Jr., Petros Levounis, 1st. ed., 2011. |
| Beschreibung: | 1 online resource |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781615371709 1615371702 1615370838 9781615370832 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1002302926 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 170829t20182018vau ob 001 0 eng | ||
| 010 | |a 2017040999 | ||
| 040 | |a DLC |b eng |e rda |e pn |c DLC |d OCLCQ |d OCLCO |d OCLCA |d YDX |d CHVBK |d OCLCO |d EZ9 |d OCLCO |d OCLCF |d N$T |d AU@ |d OCLCO |d DJ1 |d OCLCQ |d OCLCA |d LOA |d COCUF |d VT2 |d USU |d KUM |d K6U |d UX1 |d OCLCO |d OCLCQ |d DST |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
| 019 | |a 1052766426 |a 1088959061 |a 1103280047 |a 1104679739 | ||
| 020 | |a 9781615371709 |q (electronic bk.) | ||
| 020 | |a 1615371702 |q (electronic bk.) | ||
| 020 | |a 1615370838 |q (pbk. ; |q alk. paper) | ||
| 020 | |a 9781615370832 | ||
| 020 | |z 9781615370832 |q (pb ; |q alk. paper) | ||
| 035 | |a (OCoLC)1002302926 |z (OCoLC)1052766426 |z (OCoLC)1088959061 |z (OCoLC)1103280047 |z (OCoLC)1104679739 | ||
| 050 | 4 | |a RC568.O45 | |
| 060 | 4 | |a WM 284 |b H236 2018 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 7 | |a 615/.7822 |2 23 | |
| 049 | |a MAIN | ||
| 130 | 0 | |a Handbook of office-based buprenorphine treatment of opioid dependence. | |
| 245 | 1 | 0 | |a Office-based buprenorphine treatment of opioid use disorder / |c edited by John A. Renner Jr., Petros Levounis, Anna T. LaRose. |
| 250 | |a Second edition. | ||
| 264 | 1 | |a Arlington, Virginia : |b American Psychiatric Association Publishing, |c [2018] | |
| 264 | 4 | |c ©2018 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Preceded by Handbook of office-based buprenorphine treatment of opioid dependence, edited by John A. Renner Jr., Petros Levounis, 1st. ed., 2011. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Opioid use disorder in america : history and overview / John A. Renner Jr -- General opioid pharmacology / John T. Pichot, Mark T. Pichot -- Efficacy and safety of buprenorphine / Eric C. Strain, Gerard Iru I. Fernando -- Patient assessment / Petros Levounis, Jonathan Avery -- Clinical use of buprenorphine / Ricardo Restrepo, Petros Levounis -- Buprenorphine treatment in office-based settings / Jeffrey D. Baxter, Dong Chan Park -- Psychosocial and supportive treatment / Peter D. Friedmann, Tae Woo Park -- Referral, logistics, and diversion / Joji Suzuki, Claudia P. Rodriguez -- Methadone, naltrexone, and naloxone / Brad W. Stankiewicz, Saria El Haddad, Anna Terajewicz Larose -- Psychiatric comorbidity / Elie Aoun, Elinore F. McCance-Katz -- Medical comorbidity / Joseph H. Donroe, Lynn E. Fiellin, David A. Fiellin, Jeanette M. Tetrault -- Acute and chronic pain / Daniel P. Alford -- Opioid use by adolescents / Ximena Sanchez-Samper, Sharon Levy -- Women's health and pregnancy / Anna T. LaRose, Hendree E. Jones -- Comments on the case vignettes / John A. Renner Jr., Gregory Acampora. | |
| 588 | 0 | |a Online resource; title from PDF title page (EBSCO, viewed October 24, 2018). | |
| 520 | |a With a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD)-an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States. Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice. This new edition of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women's health and pregnancy. A discussion of the Comprehensive Addiction and Recovery Act (CARA). Advice for working with Alcoholics Anonymous and Narcotics Anonymous. A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs. -- Publisher. | ||
| 650 | 0 | |a Opioid abuse |x Chemotherapy. | |
| 650 | 0 | |a Buprenorphine |x Therapeutic use. | |
| 650 | 1 | 2 | |a Opioid-Related Disorders |x drug therapy |
| 650 | 2 | 2 | |a Buprenorphine |x therapeutic use |
| 650 | 2 | 2 | |a Opiate Substitution Treatment |
| 650 | 6 | |a Toxicomanie aux opiacés |x Chimiothérapie. | |
| 650 | 6 | |a Buprénorphine |x Emploi en thérapeutique. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Buprenorphine |x Therapeutic use |2 fast | |
| 650 | 7 | |a Opioid abuse |x Chemotherapy |2 fast | |
| 700 | 1 | |a Renner, John A., |c Jr., |d 1938- |e editor. |1 https://id.oclc.org/worldcat/entity/E39PCjCxQfRpjHk76wjp79fgDm |0 http://id.loc.gov/authorities/names/n2010182580 | |
| 700 | 1 | |a Levounis, Petros, |e editor. |0 http://id.loc.gov/authorities/names/n2008023316 | |
| 700 | 1 | |a LaRose, Anna T., |d 1979- |e editor. |1 https://id.oclc.org/worldcat/entity/E39PCjMyh86DmFbVgQY4kcfhh3 |0 http://id.loc.gov/authorities/names/n2017186942 | |
| 758 | |i has work: |a Handbook of office-based buprenorphine treatment of opioid dependence (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFMqyd4vgvYqHrdXtjgPKm |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Handbook of office-based buprenorphine treatment of opioid dependence. |t Office-based buprenorphine treatment of opioid use disorder. |b Second edition. |d Arlington, Virginia : American Psychiatric Association Publishing, [2018] |z 9781615370832 |w (DLC) 2017039793 |w (OCoLC)1001811331 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1713559 |3 Volltext |
| 938 | |a EBSCOhost |b EBSC |n 1713559 | ||
| 938 | |a YBP Library Services |b YANK |n 15171232 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1002302926 |
|---|---|
| _version_ | 1816882398811389952 |
| adam_text | |
| any_adam_object | |
| author2 | Renner, John A., Jr., 1938- Levounis, Petros LaRose, Anna T., 1979- |
| author2_role | edt edt edt |
| author2_variant | j a r ja jar p l pl a t l at atl |
| author_GND | http://id.loc.gov/authorities/names/n2010182580 http://id.loc.gov/authorities/names/n2008023316 http://id.loc.gov/authorities/names/n2017186942 |
| author_facet | Renner, John A., Jr., 1938- Levounis, Petros LaRose, Anna T., 1979- |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC568 |
| callnumber-raw | RC568.O45 |
| callnumber-search | RC568.O45 |
| callnumber-sort | RC 3568 O45 |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | Opioid use disorder in america : history and overview / John A. Renner Jr -- General opioid pharmacology / John T. Pichot, Mark T. Pichot -- Efficacy and safety of buprenorphine / Eric C. Strain, Gerard Iru I. Fernando -- Patient assessment / Petros Levounis, Jonathan Avery -- Clinical use of buprenorphine / Ricardo Restrepo, Petros Levounis -- Buprenorphine treatment in office-based settings / Jeffrey D. Baxter, Dong Chan Park -- Psychosocial and supportive treatment / Peter D. Friedmann, Tae Woo Park -- Referral, logistics, and diversion / Joji Suzuki, Claudia P. Rodriguez -- Methadone, naltrexone, and naloxone / Brad W. Stankiewicz, Saria El Haddad, Anna Terajewicz Larose -- Psychiatric comorbidity / Elie Aoun, Elinore F. McCance-Katz -- Medical comorbidity / Joseph H. Donroe, Lynn E. Fiellin, David A. Fiellin, Jeanette M. Tetrault -- Acute and chronic pain / Daniel P. Alford -- Opioid use by adolescents / Ximena Sanchez-Samper, Sharon Levy -- Women's health and pregnancy / Anna T. LaRose, Hendree E. Jones -- Comments on the case vignettes / John A. Renner Jr., Gregory Acampora. |
| ctrlnum | (OCoLC)1002302926 |
| dewey-full | 615/.7822 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.7822 |
| dewey-search | 615/.7822 |
| dewey-sort | 3615 47822 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | Second edition. |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06026cam a2200661 i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1002302926</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">170829t20182018vau ob 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2017040999</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DLC</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">DLC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">YDX</subfield><subfield code="d">CHVBK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">EZ9</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">N$T</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DJ1</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">LOA</subfield><subfield code="d">COCUF</subfield><subfield code="d">VT2</subfield><subfield code="d">USU</subfield><subfield code="d">KUM</subfield><subfield code="d">K6U</subfield><subfield code="d">UX1</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DST</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1052766426</subfield><subfield code="a">1088959061</subfield><subfield code="a">1103280047</subfield><subfield code="a">1104679739</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781615371709</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1615371702</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1615370838</subfield><subfield code="q">(pbk. ;</subfield><subfield code="q">alk. paper)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781615370832</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781615370832</subfield><subfield code="q">(pb ;</subfield><subfield code="q">alk. paper)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1002302926</subfield><subfield code="z">(OCoLC)1052766426</subfield><subfield code="z">(OCoLC)1088959061</subfield><subfield code="z">(OCoLC)1103280047</subfield><subfield code="z">(OCoLC)1104679739</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC568.O45</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WM 284</subfield><subfield code="b">H236 2018</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615/.7822</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="130" ind1="0" ind2=" "><subfield code="a">Handbook of office-based buprenorphine treatment of opioid dependence.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Office-based buprenorphine treatment of opioid use disorder /</subfield><subfield code="c">edited by John A. Renner Jr., Petros Levounis, Anna T. LaRose.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Arlington, Virginia :</subfield><subfield code="b">American Psychiatric Association Publishing,</subfield><subfield code="c">[2018]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Preceded by Handbook of office-based buprenorphine treatment of opioid dependence, edited by John A. Renner Jr., Petros Levounis, 1st. ed., 2011.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Opioid use disorder in america : history and overview / John A. Renner Jr -- General opioid pharmacology / John T. Pichot, Mark T. Pichot -- Efficacy and safety of buprenorphine / Eric C. Strain, Gerard Iru I. Fernando -- Patient assessment / Petros Levounis, Jonathan Avery -- Clinical use of buprenorphine / Ricardo Restrepo, Petros Levounis -- Buprenorphine treatment in office-based settings / Jeffrey D. Baxter, Dong Chan Park -- Psychosocial and supportive treatment / Peter D. Friedmann, Tae Woo Park -- Referral, logistics, and diversion / Joji Suzuki, Claudia P. Rodriguez -- Methadone, naltrexone, and naloxone / Brad W. Stankiewicz, Saria El Haddad, Anna Terajewicz Larose -- Psychiatric comorbidity / Elie Aoun, Elinore F. McCance-Katz -- Medical comorbidity / Joseph H. Donroe, Lynn E. Fiellin, David A. Fiellin, Jeanette M. Tetrault -- Acute and chronic pain / Daniel P. Alford -- Opioid use by adolescents / Ximena Sanchez-Samper, Sharon Levy -- Women's health and pregnancy / Anna T. LaRose, Hendree E. Jones -- Comments on the case vignettes / John A. Renner Jr., Gregory Acampora.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Online resource; title from PDF title page (EBSCO, viewed October 24, 2018).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">With a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD)-an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States. Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice. This new edition of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women's health and pregnancy. A discussion of the Comprehensive Addiction and Recovery Act (CARA). Advice for working with Alcoholics Anonymous and Narcotics Anonymous. A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs. -- Publisher.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Opioid abuse</subfield><subfield code="x">Chemotherapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Buprenorphine</subfield><subfield code="x">Therapeutic use.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Opioid-Related Disorders</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Buprenorphine</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Opiate Substitution Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Toxicomanie aux opiacés</subfield><subfield code="x">Chimiothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Buprénorphine</subfield><subfield code="x">Emploi en thérapeutique.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Buprenorphine</subfield><subfield code="x">Therapeutic use</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Opioid abuse</subfield><subfield code="x">Chemotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Renner, John A.,</subfield><subfield code="c">Jr.,</subfield><subfield code="d">1938-</subfield><subfield code="e">editor.</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjCxQfRpjHk76wjp79fgDm</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2010182580</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Levounis, Petros,</subfield><subfield code="e">editor.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2008023316</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">LaRose, Anna T.,</subfield><subfield code="d">1979-</subfield><subfield code="e">editor.</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjMyh86DmFbVgQY4kcfhh3</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2017186942</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Handbook of office-based buprenorphine treatment of opioid dependence (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFMqyd4vgvYqHrdXtjgPKm</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Handbook of office-based buprenorphine treatment of opioid dependence.</subfield><subfield code="t">Office-based buprenorphine treatment of opioid use disorder.</subfield><subfield code="b">Second edition.</subfield><subfield code="d">Arlington, Virginia : American Psychiatric Association Publishing, [2018]</subfield><subfield code="z">9781615370832</subfield><subfield code="w">(DLC) 2017039793</subfield><subfield code="w">(OCoLC)1001811331</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1713559</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">1713559</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">15171232</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-on1002302926 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:27:59Z |
| institution | BVB |
| isbn | 9781615371709 1615371702 1615370838 9781615370832 |
| language | English |
| lccn | 2017040999 |
| oclc_num | 1002302926 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource |
| psigel | ZDB-4-EBA |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| publisher | American Psychiatric Association Publishing, |
| record_format | marc |
| spelling | Handbook of office-based buprenorphine treatment of opioid dependence. Office-based buprenorphine treatment of opioid use disorder / edited by John A. Renner Jr., Petros Levounis, Anna T. LaRose. Second edition. Arlington, Virginia : American Psychiatric Association Publishing, [2018] ©2018 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Preceded by Handbook of office-based buprenorphine treatment of opioid dependence, edited by John A. Renner Jr., Petros Levounis, 1st. ed., 2011. Includes bibliographical references and index. Opioid use disorder in america : history and overview / John A. Renner Jr -- General opioid pharmacology / John T. Pichot, Mark T. Pichot -- Efficacy and safety of buprenorphine / Eric C. Strain, Gerard Iru I. Fernando -- Patient assessment / Petros Levounis, Jonathan Avery -- Clinical use of buprenorphine / Ricardo Restrepo, Petros Levounis -- Buprenorphine treatment in office-based settings / Jeffrey D. Baxter, Dong Chan Park -- Psychosocial and supportive treatment / Peter D. Friedmann, Tae Woo Park -- Referral, logistics, and diversion / Joji Suzuki, Claudia P. Rodriguez -- Methadone, naltrexone, and naloxone / Brad W. Stankiewicz, Saria El Haddad, Anna Terajewicz Larose -- Psychiatric comorbidity / Elie Aoun, Elinore F. McCance-Katz -- Medical comorbidity / Joseph H. Donroe, Lynn E. Fiellin, David A. Fiellin, Jeanette M. Tetrault -- Acute and chronic pain / Daniel P. Alford -- Opioid use by adolescents / Ximena Sanchez-Samper, Sharon Levy -- Women's health and pregnancy / Anna T. LaRose, Hendree E. Jones -- Comments on the case vignettes / John A. Renner Jr., Gregory Acampora. Online resource; title from PDF title page (EBSCO, viewed October 24, 2018). With a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD)-an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States. Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice. This new edition of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women's health and pregnancy. A discussion of the Comprehensive Addiction and Recovery Act (CARA). Advice for working with Alcoholics Anonymous and Narcotics Anonymous. A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs. -- Publisher. Opioid abuse Chemotherapy. Buprenorphine Therapeutic use. Opioid-Related Disorders drug therapy Buprenorphine therapeutic use Opiate Substitution Treatment Toxicomanie aux opiacés Chimiothérapie. Buprénorphine Emploi en thérapeutique. MEDICAL Pharmacology. bisacsh Buprenorphine Therapeutic use fast Opioid abuse Chemotherapy fast Renner, John A., Jr., 1938- editor. https://id.oclc.org/worldcat/entity/E39PCjCxQfRpjHk76wjp79fgDm http://id.loc.gov/authorities/names/n2010182580 Levounis, Petros, editor. http://id.loc.gov/authorities/names/n2008023316 LaRose, Anna T., 1979- editor. https://id.oclc.org/worldcat/entity/E39PCjMyh86DmFbVgQY4kcfhh3 http://id.loc.gov/authorities/names/n2017186942 has work: Handbook of office-based buprenorphine treatment of opioid dependence (Text) https://id.oclc.org/worldcat/entity/E39PCFMqyd4vgvYqHrdXtjgPKm https://id.oclc.org/worldcat/ontology/hasWork Print version: Handbook of office-based buprenorphine treatment of opioid dependence. Office-based buprenorphine treatment of opioid use disorder. Second edition. Arlington, Virginia : American Psychiatric Association Publishing, [2018] 9781615370832 (DLC) 2017039793 (OCoLC)1001811331 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1713559 Volltext |
| spellingShingle | Office-based buprenorphine treatment of opioid use disorder / Opioid use disorder in america : history and overview / John A. Renner Jr -- General opioid pharmacology / John T. Pichot, Mark T. Pichot -- Efficacy and safety of buprenorphine / Eric C. Strain, Gerard Iru I. Fernando -- Patient assessment / Petros Levounis, Jonathan Avery -- Clinical use of buprenorphine / Ricardo Restrepo, Petros Levounis -- Buprenorphine treatment in office-based settings / Jeffrey D. Baxter, Dong Chan Park -- Psychosocial and supportive treatment / Peter D. Friedmann, Tae Woo Park -- Referral, logistics, and diversion / Joji Suzuki, Claudia P. Rodriguez -- Methadone, naltrexone, and naloxone / Brad W. Stankiewicz, Saria El Haddad, Anna Terajewicz Larose -- Psychiatric comorbidity / Elie Aoun, Elinore F. McCance-Katz -- Medical comorbidity / Joseph H. Donroe, Lynn E. Fiellin, David A. Fiellin, Jeanette M. Tetrault -- Acute and chronic pain / Daniel P. Alford -- Opioid use by adolescents / Ximena Sanchez-Samper, Sharon Levy -- Women's health and pregnancy / Anna T. LaRose, Hendree E. Jones -- Comments on the case vignettes / John A. Renner Jr., Gregory Acampora. Opioid abuse Chemotherapy. Buprenorphine Therapeutic use. Opioid-Related Disorders drug therapy Buprenorphine therapeutic use Opiate Substitution Treatment Toxicomanie aux opiacés Chimiothérapie. Buprénorphine Emploi en thérapeutique. MEDICAL Pharmacology. bisacsh Buprenorphine Therapeutic use fast Opioid abuse Chemotherapy fast |
| title | Office-based buprenorphine treatment of opioid use disorder / |
| title_alt | Handbook of office-based buprenorphine treatment of opioid dependence. |
| title_auth | Office-based buprenorphine treatment of opioid use disorder / |
| title_exact_search | Office-based buprenorphine treatment of opioid use disorder / |
| title_full | Office-based buprenorphine treatment of opioid use disorder / edited by John A. Renner Jr., Petros Levounis, Anna T. LaRose. |
| title_fullStr | Office-based buprenorphine treatment of opioid use disorder / edited by John A. Renner Jr., Petros Levounis, Anna T. LaRose. |
| title_full_unstemmed | Office-based buprenorphine treatment of opioid use disorder / edited by John A. Renner Jr., Petros Levounis, Anna T. LaRose. |
| title_short | Office-based buprenorphine treatment of opioid use disorder / |
| title_sort | office based buprenorphine treatment of opioid use disorder |
| topic | Opioid abuse Chemotherapy. Buprenorphine Therapeutic use. Opioid-Related Disorders drug therapy Buprenorphine therapeutic use Opiate Substitution Treatment Toxicomanie aux opiacés Chimiothérapie. Buprénorphine Emploi en thérapeutique. MEDICAL Pharmacology. bisacsh Buprenorphine Therapeutic use fast Opioid abuse Chemotherapy fast |
| topic_facet | Opioid abuse Chemotherapy. Buprenorphine Therapeutic use. Opioid-Related Disorders drug therapy Buprenorphine therapeutic use Opiate Substitution Treatment Toxicomanie aux opiacés Chimiothérapie. Buprénorphine Emploi en thérapeutique. MEDICAL Pharmacology. Buprenorphine Therapeutic use Opioid abuse Chemotherapy |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1713559 |
| work_keys_str_mv | UT handbookofofficebasedbuprenorphinetreatmentofopioiddependence AT rennerjohna officebasedbuprenorphinetreatmentofopioidusedisorder AT levounispetros officebasedbuprenorphinetreatmentofopioidusedisorder AT laroseannat officebasedbuprenorphinetreatmentofopioidusedisorder |